@antibotter says....
AstraZeneca has not began phase 2 of the seamless phase 1/2 clinical trial of AZD0466 yet
JF & Co. state in the December 2021 Shareholder Newsletter dated 16 Dec 2021 and again in the recent Quarterly report issued on 28 January 2022 the complete opposite ?
Content from Shareholder Newsletter Dec 2021
![]()
Who to believe I wonder given the phase 1 trial has finished and JF & Co. state as recent as December and again in January that they are "actively enrolling patients" ? lol
Content from Quarterly Jan 2022
![]()
I also wonder if the 100 years of commercial experience was smart enough to secure additional upfront milestone payments in the AstraZeneca agreement when a new trial is started using the same drug ... for example; AZD0466
Are Starpharma entitled to another milestone payment for this new trial starting this month (Feb) if it is the same DEP drug already being trialed for a different treatment or will AstraZeneca be able to say yeah, nah ... no money for you as it is the same indication ??![]()
- Forums
- ASX - By Stock
- SPL
- Next key milestone payment
Next key milestone payment, page-2
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.8¢ |
Change
0.003(3.16%) |
Mkt cap ! $38.76M |
Open | High | Low | Value | Volume |
9.8¢ | 9.8¢ | 9.2¢ | $155.3K | 1.634M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 49883 | 9.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.8¢ | 96172 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 49883 | 0.096 |
2 | 265000 | 0.095 |
1 | 227075 | 0.093 |
2 | 68260 | 0.092 |
1 | 50050 | 0.091 |
Price($) | Vol. | No. |
---|---|---|
0.098 | 96172 | 5 |
0.099 | 33000 | 2 |
0.100 | 148705 | 4 |
0.105 | 96531 | 4 |
0.110 | 39609 | 6 |
Last trade - 15.49pm 24/07/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online